Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2020 08:00 ET | Source: InspireMD, Inc.

InspireMD’s CGuard™ Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany

TEL AVIV, Israel, Jan. 27, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,...
January 06, 2020 08:00 ET | Source: InspireMD, Inc.

InspireMD Announces Strong Preliminary Fourth Quarter 2019 Revenue and Reports Inducement Award Under NYSE American Company Guide §711(a)

TEL AVIV, Israel, Jan. 06, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid...
December 10, 2019 08:00 ET | Source: InspireMD, Inc.

InspireMD Announces Planned Leadership Transition

Life sciences industry veteran Marvin Slosman appointed Chief Executive Officer Appointment adds significant medical technology commercialization experience to the InspireMD team TEL AVIV, Israel,...
November 26, 2019 08:00 ET | Source: InspireMD, Inc.

InspireMD Reports Updated Positive CGuard™ EPS Data Presented at VEITH 2019

CGuard™ EPS clinical data featured as a prominent discussion point in multiple key presentations Data from investigator-initiated multicenter, 729-patient IRONGUARD 2 study suggests that the use...
November 12, 2019 08:58 ET | Source: InspireMD, Inc.

UPDATE: InspireMD Announces Third Quarter 2019 Financial Results

Strong revenue driven by record orders of CGuard™ EPS Management to host investor conference call today, November 12, at 8:30am ET TEL AVIV, Israel, Nov. 12, 2019 (GLOBE NEWSWIRE) -- InspireMD,...
November 12, 2019 07:00 ET | Source: InspireMD, Inc.

InspireMD Announces Third Quarter 2019 Financial Results

Strong revenue driven by record orders of CGuard™ EPS Management to host investor conference call today, November 12, at 8:30am ET TEL AVIV, Israel, Nov. 12, 2019 (GLOBE NEWSWIRE) -- InspireMD,...
November 05, 2019 08:00 ET | Source: InspireMD, Inc.

InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12

TEL AVIV, Israel, Nov. 05, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the...
September 19, 2019 21:12 ET | Source: InspireMD, Inc.

InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering

TEL AVIV, Israel, Sept. 19, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by...
September 09, 2019 08:05 ET | Source: InspireMD, Inc.

InspireMD Provides Business Update

TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by...
September 09, 2019 08:00 ET | Source: InspireMD, Inc.

InspireMD to Present at the HC Wainwright 21st Annual Global Investment Conference

TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right